Perspectives from across the ICU
Whether it's starting a new CRRT program or optimizing your existing program, we understand there are a multitude of considerations that go into making this successful. And one of those things is making sure everyone on the team is involved in that process. We invite you to listen to some of the experiences and recommendations our doctors, nurses and pharmacists have had with the Baxter CRRT program. Because partnering with you for a CRRT program built for your ICU is what drives us.
complete support  |  patient safety  |  flexibility
 
Whether it's starting a new CRRT program or optimizing your existing program, we understand there are a multitude of considerations that go into making this successful. And one of those things is making sure everyone on the team is involved in that process. We invite you to listen to some of the experiences and recommendations our doctors, nurses and pharmacists have had with the Baxter CRRT program. Because partnering with you for a CRRT program built for your ICU is what drives us.
complete support  |  patient safety  |  flexibility
 
Clinical Questions
 
 
 
 
Featured Presentation
CRRT in the Era of Drug Shortages
 
 
 
Want more information?
Speak with a Baxter representative or
connect with us at an event.
Acute Therapies Institute
This initiative brings together the kidney care
community to learn from industry experts and
share best practices.
 
 
 
The PRISMAFLEX Control Unit is intended for:
Continuous Renal Replacement Therapy (CRRT) for patients weighing 20 kilograms or more with acute renal failure and/or fluid overload.
Therapeutic Plasma Exchange (TPE) therapy for patients weighing 20 kilograms or more with diseases where fluid removal of plasma components is indicated.
Rx Only. For safe and proper use of products mentioned herein refer to the appropriate Instructions for Use or Operator's Manual.

PHOXILLUM Renal Replacement Solution Indications and Important Risk Information

Indications
PHOXILLUM solution is indicated in pediatric and adult patients for use as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace plasma volume removed by ultrafiltration and to correct electrolyte and acid-base imbalances. It may also be used in case of drug poisoning when CRRT is used to remove dialyzable substances.

Important Risk Information
PHOXILLUM solution can affect electrolytes and volume and may result in hyperkalemia or hyperphosphatemia. Monitor hemodynamic status and fluid inputs and outputs, potassium, phosphorous, calcium, other electrolytes and acid-base balance throughout the procedure. Abnormalities may be corrected by changing the formulation of replacement solution and/or dialysate, supplementation, or adjusting flow rates appropriately. PHOXILLUM replacement solutions contain hydrogen phosphate, a weak acid that may increase the risk of metabolic acidosis. PHOXILLUM solution can effect blood glucose levels resulting in hypo- or hyper-glycemia depending upon the dextrose content of the replacement solution. Monitor blood glucose levels regularly. Patients may require initiation of or modification of antidiabetic therapy or other corrective measures during treatment.

PRISMASOL Renal Replacement Solution

Indications
PRISMASOL Renal Replacement Solution is indicated in pediatric and adult patients for use as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace plasma volume removed by ultrafiltration and to correct electrolytes and acid-base imbalances. PRISMASOL Solution may also be used in case of drug poisoning when CRRT is used to remove dialyzable substances.

Important Risk Information
PRISMASOL Renal Replacement Solution is contraindicated in patients with known hypersensitivities to this product.
PRISMASOL Solution can affect electrolytes and volume and may result in hyperkalemia or   hyperphosphatemia. Monitor hemodynamic status and fluid inputs and outputs, potassium, phosphorous, other electrolytes and acid-base balance throughout the procedure. Abnormalities may be corrected by changing the formulation of replacement solution and/or dialysate, supplementation, or adjusting flow rates appropriately. The use of PRISMASOL Solutions containing dextrose can affect blood glucose levels resulting in hypo- or hyper-glycemia depending upon the dextrose content of the replacement solution. Patients may require initiation of or modification of antidiabetic therapy or other corrective measures during treatment.
Please see PHOXILLUM and PRISMASOL Solutions full Prescribing Information.